Controversy Over Trump’s Proposed Research Rule
A proposed rule from the Trump administration is facing extensive criticism. This rule, initiated by the White House Office of Management and Budget, aims to alter the funding of scientific grants significantly. Nearly 342,000 comments were submitted regarding this proposal, with the overwhelming majority expressing opposition. The agency plans to finalize the rule by October 1.
If implemented, the rule would require senior administration officials to review all discretionary federal government awards. These officials could reject funding based on alignment with the president’s agenda. Existing awards might also be canceled arbitrarily without meaningful justification.
This rule would further impose restrictions on research related to diversity, equity, and inclusion. These restrictions would also apply to grants that are focused on gender issues, and it would broadly prohibit international scientific collaborations. Such limitations could challenge America’s leadership in biomedical research, especially as China is rapidly advancing in this field.
The White House describes the rule as a measure to enhance transparency and reduce government waste, fraud, and abuse. However, 57 prominent patient advocacy organizations, representing millions of Americans with various health conditions, have urged congressional leaders to convince the OMB to withdraw this rule. These groups argue that it could harm America’s status as a global scientific leader, potentially endangering the future of clinical trials and funding.
The Hill’s Healthcare newsletter monitors the influence of Washington on health policies. Recently, the Department of Health and Human Services’ watchdog reported generating $5.56 billion in recoveries and savings over six months, alongside barring over 1,200 individuals and entities from federal programs.
In other news, the recent death of Sen. Lindsey Graham, attributed to an aortic dissection, has brought attention to this rare and often fatal condition. Additionally, a second American diagnosed with Ebola was treated in Germany.
Upcoming healthcare news includes a Senate HELP Committee confirmation hearing for key CDC and HHS nominees. Meanwhile, a group of state attorneys general is suing the Department of Education regarding the termination of mental health grants for schools, amid ongoing disputes over educational funding.
In state and local healthcare updates, California’s Medicaid funding adaptation, the closure of health clinics in Virginia, and Missouri’s new healthcare legislation highlight regional policy shifts. Federal proposals related to healthcare, such as Trump’s HHS withdrawal of threats concerning Medicare and Medicaid funding for trans care, continue to evolve.